跳转至内容
Merck
CN

V900370

L-肌肽

98%, Vetec

别名:

β-丙氨酰-L-组氨酸

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C9H14N4O3
化学文摘社编号:
分子量:
226.23
UNSPSC Code:
12352209
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
87671
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

L-肌肽, Vetec, reagent grade, 98%

InChI

1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1

SMILES string

NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O

InChI key

CQOVPNPJLQNMDC-ZETCQYMHSA-N

grade

reagent grade

product line

Vetec

assay

98%

form

powder

color

white to off-white

mp

253 °C (dec.) (lit.)

storage temp.

−20°C

正在寻找类似产品? 访问 产品对比指南

Biochem/physiol Actions

L-肌肽一种二肽,以毫摩尔浓度存在于脑、肌肉和眼睛晶状体中。 在模型系统中,它是一种有效的抗氧化剂,可清除氧自由基和过渡金属离子。 它可以阻断由次氯酸根阴离子以及乙醛、甲醛和丙二醛(脂质过氧化的主要产物)等有毒醛类诱导的蛋白质-蛋白质和蛋白质-DNA交联。 它还能抑制醛糖和酮糖还原糖诱导的非酶促蛋白糖化,并抑制毒性晚期糖基化终产物(AGE)的形成。这些活性使其被用于对衰老、动脉粥样硬化、阿尔茨海默病和糖尿病的继发性影响的研究。
具有强抗氧化性和抗糖化活性的二肽;阻断由反应性醛诱导的非酶促糖基化和蛋白质交联。

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sanne Stegen et al.
PloS one, 10(3), e0121062-e0121062 (2015-03-25)
Muscle carnosine and its methylated form anserine are histidine-containing dipeptides. Both dipeptides have the ability to quench reactive carbonyl species and previous studies have shown that endogenous tissue levels are decreased in chronic diseases, such as diabetes. Rodent study: Skeletal
Alexander A Boldyrev et al.
Physiological reviews, 93(4), 1803-1845 (2013-10-19)
Carnosine (β-alanyl-l-histidine) was discovered in 1900 as an abundant non-protein nitrogen-containing compound of meat. The dipeptide is not only found in skeletal muscle, but also in other excitable tissues. Most animals, except humans, also possess a methylated variant of carnosine
K N Roy Chengappa et al.
Schizophrenia research, 142(1-3), 145-152 (2012-10-27)
Targeting glutamatergic dysfunction provides an exciting opportunity to improve cognitive impairment in schizophrenia. One treatment approach has targeted inadequate antioxidant defenses at glutamatergic synapses. Animal and human data suggest NMDA antagonists worsen executive cognitive controls--e.g. increase perseverative responses and impair
Francesco Attanasio et al.
Chembiochem : a European journal of chemical biology, 14(5), 583-592 (2013-02-27)
Aggregation of the amyloid-β peptide (Aβ) into fibrillar structures is a hallmark of Alzheimer's disease. Thus, preventing self-assembly of the Aβ peptide is an attractive therapeutic strategy. Here, we used experimental techniques and atomistic simulations to investigate the influence of
Johann Edge et al.
Experimental physiology, 98(2), 481-490 (2012-08-28)
It has been hypothesized that exercise-induced changes in metabolites and ions are crucial in the adaptation of contracting muscle. We tested this hypothesis by comparing adaptations to two different interval-training protocols (differing only in the rest duration between intervals), which

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持